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Context: Adrenarche is a gradual process, but its programming is unknown.
Objective: The objective of this article is to examine the trajectory of dehydroepiandrosterone sulfate 
(DHEAS) from age 1 to 6 years and the associations of early growth with DHEAS concentration by 
age 6 years.
Design and participants: Longitudinal data from a population sample of 78 children (43 girls) with 
serum samples for DHEAS and insulin-like growth factor 1 (IGF-1) measurements available at ages 
1 and 6 years.
Main outcome measure: Serum DHEAS concentration at age 6 years.
Results: DHEAS concentration at age 1 year correlated with DHEAS concentration at age 6 years 
(r = 0.594, P < .001). DHEAS levels at age 6 years increased with tertiles of DHEAS at age 1 year 
(medians (µg/dL); 4.2, 14.4, 22.6; P < .001) and with those of greater increase in length by age 1 year 
(6.0, 11.7, 16.4; P = .047), and decreased with tertiles of birth length (17.7, 13.3, 7.1; P = .042). In a 
regression model including birth size, biochemical covariates at age 1 year, and growth measures by 
age 6 years, higher DHEAS concentration at age 1 year was an independent determinant of falling 
into the highest DHEAS tertile at age 6 years.
Conclusions: Higher serum DHEAS concentrations already at age 1 year are associated with those 
at age 6 years. Also, shorter birth length and rapid catch-up growth in length by age 1 year are asso-
ciated with higher DHEAS concentrations at age 6 years. These results corroborate the early origin 
of adrenarche and strongly suggest that part of adrenarchal programming already takes place by the 
end of infancy.
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This is an Open Access article distributed under the terms of the Creative Commons Attribution-
NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which 
permits non-commercial reproduction and distribution of the work, in any medium, provided 
the original work is not altered or transformed in any way, and that the work is properly cited. 
For commercial re-use, please contact journals.permissions@oup.com








/jes/article-abstract/4/2/bvaa012/5719609 by guest on 31 M
arch 2020
2 | Journal of the Endocrine Society | doi: 10.1210/jendso/bvaa012
Adrenarche refers to a progressive increase of adrenal androgen secretion in mid-
childhood that results from the maturation of the adrenocortical zona reticularis [1]. 
Dehydroepiandrosterone sulfate (DHEAS), secreted from zona reticularis of the adrenal 
cortex, is a surrogate marker of adrenal androgen production. DHEAS and other adrenal 
androgen products, dehydroepiandrosterone and androstenedione, act as precursors for pe-
ripheral cells that can convert them to androgens with a capability to activate the androgen 
receptor [2]. Adult-type body odor, greasiness of skin and hair, acne, and growth of axillary 
and pubic hair are the clinical signs of androgen action [1].
Previous studies have shown that adrenal androgen secretion in mid-childhood is asso-
ciated with early life factors such as nutritional status and early growth, including birth 
size. Low birth weight or being born small for gestational age have been associated with 
higher adrenal androgen secretion in mid-childhood [3], especially when followed by rapid 
early catch-up growth or weight gain [4, 5]. Also, increased weight gain and linear growth 
later in childhood [6, 7], and increased adiposity and higher intake of several nutrients [8, 
9] have been linked with higher DHEAS levels in mid-childhood. Similarly, the secretion 
pattern of insulin-like growth factor 1 (IGF-1) seems to be programmed in early childhood 
because circulating IGF-1 levels at prepubertal age are associated with birth size and early 
growth rate [10]. On the other hand, several studies have demonstrated that children with 
premature adrenarche have increased growth in length/height and weight gain already in 
the first years of life [11, 12], and they tend to have higher circulating IGF-1 levels in child-
hood compared to their peers [11, 13].
Although growing evidence suggests that early growth modifies gradual adrenal mat-
uration, it is not well known at which age the patterns of adrenal androgen secretion are 
programmed and if early serum DHEAS levels are associated with DHEAS concentrations 
in later childhood. We hypothesized that the patterns of adrenal androgen secretion are pro-
grammed already by the end of infancy, and therefore our main aim was to investigate the 
associations of DHEAS at age 1 year and early growth with serum DHEAS concentrations 
in mid-childhood at age 6 years. Additionally, because IGF-1 has close associations with 
linear growth [14] and adrenarche [13, 15], we investigated serum IGF-1 concentrations at 
age 1 and 6 years in relation to growth and DHEAS measures.
1.  Participants and Methods
A.  Participants and Design
A sample of 78 children (43 girls) in the present study were originally the participants of 
the Finnish LUKAS birth cohort studies recruited from September 2002 to May 2004 [16]. 
LUKAS1 cohort is a Finnish part of the European birth cohort study PASTURE (Protection 
against Allergy Study in Rural Environments) [17] among farmers and nonfarmers, whereas 
the second half of the cohort (LUKAS2) consists of unselected children [16]. All children without 
any long-term medication and with data on DHEAS and IGF-1 measurements available both 
at ages 1 and 6 years were included in the present study. Ethical approval of this study was 
granted by the research ethics committee of the Hospital District of Northern Savo (Kuopio, 
Finland). Written consent forms were obtained from the parents of the participating children.
B.  Clinical Assessment
Birth measures were recorded by midwives working on labor wards and measured with 
standardized infantometers and calibrated scales to the accuracy of 0.1 cm and 0.01 kg, re-
spectively. If necessary, birth measures were supplemented later from the records of local child 
health centers. All anthropometric measures were recorded by a trained nurse, as part of the 
routine health check-up in local child health center at age 1 year and by the research team at 
age 6 years. Length at age 1 year was measured using a standardized infantometer and height 
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0.1 cm. Weight was measured using a calibrated electric scale to the accuracy of 0.1 kg. The 
appearance of androgenic signs was questioned by a structured questionnaire of the parents 
and verified by clinical examination at age 6 years. Adult-type body odor was recorded if the 
parents reported a clear change in the type of axillary odor and/or a frequent need for antiper-
spirant, or if axillary adult-type odor and wetness were present in the clinical examination. 
Greasiness of hair was recorded if the parents reported a clear greasiness of hair and/or need 
for daily hair wash. Tanner pubertal stage [18, 19], axillary hair, acne, and comedones were 
evaluated by a trained nurse in systematic examination. Testicular volumes were estimated 
with an orchidometer. According to Tanner stage, all children were prepubertal. Children with 
at least one of the following androgenic signs were considered to have clinical adrenarche: adult-
type body odor, greasiness of hair, comedones/acne, and pubic or axillary hair. Biochemical 
adrenarche was defined as serum DHEAS concentration greater than or equal to 40 µg/dL 
(1.08 µmol/l), which is above average for prepubertal children age 6 to 8 years [11].
C.  Biochemical Analyses
Blood samples were drawn and serum samples for DHEAS and IGF-1 measurements were 
stored at –80°C until assayed. We measured serum DHEAS and IGF-1 concentrations using 
enzyme-linked immunosorbent assays with a Bio-Rad model 550 microplate reader (Bio-Rad 
Laboratories Inc) and specific kits (DHEAS, cat 1950, Alpha Diagnostic, International [20]; 
IGF-1, cat E20, Mediagnost [21]). For DHEAS, the intra-assay and interassay coefficients 
of variation were 11.2% and 7.6%, respectively. For IGF-1, the corresponding values were 
11.1% and 10.6%. The detection limit was 0.5 µg/dL for DHEAS and 20 ng/mL for IGF-1.
D.  Computed Indices
All anthropometric SD scores were calculated using the current Finnish references [22, 23]. 
Regarding birth size, infant growth (∆length and ∆weight-for-length SD score from birth to 
age 1 year), later childhood growth (∆height and ∆weight-for-height SD score from ages 1 
to 6 years), and age 1 year biochemical levels, the children were divided into tertile groups 
(depicted as 1 to 3 in Figs. 1 and 2, one indicating the lowest tertile). The tertile groups were 
defined by dividing an equal number of participants to each of 3 tertiles. The ranges within 
each tertile for these parameters were as follows:
Birth length SD score: –1.90 to –0.40, –0.39 to 0.39, and 0.40 to 1.90;
Birth weight SD score: –2.00 to –0.40, –0.39 to 0.39, and 0.40 to 2.30;
∆Length SD score from birth to age 1 year: –2.44 to –0.81, –0.80 to 0.07, and 0.08 to 2.22;
∆Weight-for-length SD score from birth to age 1 year: –2.84 to –0.92, –0.91 to 0.01, and 0.02 
to 2.57;
Serum DHEAS concentration (µg/dL) at age 1 year: 0.2 to 1.4, 1.5 to 3.8, and 3.9 to 27.6;
Serum IGF-1 concentration (ng/mL) at age 1 year: 32.3 to 59.4, 59.5 to 86.3, and 86.4 to 
184.8;
∆Height SD score from ages 1 to 6 years: –3.08 to –0.23, –0.22 to 1.11, and 1.12 to 3.42; and
∆Weight-for-height SD score from ages 1 to 6 years: –2.22 to –0.24, –0.23 to 0.61, and 0.62 
to 2.74.
E.  Statistical Analyses
We performed all statistical analyses using SPSS 24.0 software (IBM Corp). Differences 
between the groups with P less than .05 were considered significant. The normality of the 
distributions for all continuous variables were first inspected visually from the histograms 
and using the Shapiro-Wilk test. Correlations between the studied parameters were 
analyzed using the Spearman rank order correlation test. To compare the differences 
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continuous variables, and χ 2 test for categorical variables. When analyzing differences be-
tween the tertile groups, we used the Kruskal-Wallis test. Determinants of falling into the 
highest DHEAS tertile at age 6 years were analyzed using binary logistic regression models. 
Continuous nonnormally distributed covariates in the regression model were first logarith-
mically transformed and then used as SD scores as continuous variables.
3. Results
Characteristics of the children at birth, at age 1  year, and at age 6  years are shown in 
Table  1. One girl and 2 boys had been born slightly preterm (at the gestational age of 
Figure 1. Serum dehydroepiandrosterone sulfate (DHEAS) concentrations (µg/dL) at age 
6 years in the 78 children of the study by A, DHEAS and B, insulin-like growth factor 1 (IGF-
1) tertiles at age 1 year (group 1 indicating the lowest tertile). Horizontal solid lines depict 
medians, gray boxes represent interquartile ranges (IQR), and whiskers indicate variability 
outside the upper and lower quartiles. Differences between the tertile groups were analyzed 
using the Kruskal-Wallis test. Median (IQR) serum DHEAS concentration (µg/dL) in each 
tertile, respectively: A, by DHEAS tertiles at age 1 year, 4.2 (2.3-7.6), 14.4 (6.9-22.1), and 22.6 
(12.0-36.2); and B, by IGF-1 tertiles at age 1 year, 7.4 (3.1-17.0), 13.6 (5.6-30.1), and 14.8 (7.5-
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Figure 2. Serum dehydroepiandrosterone sulfate (DHEAS) concentration (µg/dL) at age 6 years 
in the 78 children of the study by A and B, birth size, and C and D, growth from birth to age 1 year, 
or E and F, from age 1 to 6 years. For each studied variable, children were divided into tertile 
groups, with group 1 indicating the lowest tertile. Horizontal solid lines depict medians, gray boxes 
represent interquartile ranges (IQR), and whiskers indicate variability outside the upper and 
lower quartiles. Differences between the tertile groups were analyzed using the Kruskal-Wallis 
test. Median (IQR) serum DHEAS concentrations (µg/dL) in each tertile, respectively: A, by birth 
length SDS tertiles, 17.7 (8.2-23.2), 13.3 (4.9-26.4), and 7.1 (2.7-14.1); B, by birth weight SDS 
tertiles, 15.8 (6.5-22.7), 14.4 (5.7-25.7), and 7.6 (2.5-20.8); C, by ∆length SDS 0-1y tertiles, 6.0 (2.8-
18.4), 11.7 (4.8-22.4), and 16.4 (8.6-25.2); D, by ∆weight-for-length SDS 0-1y tertiles, 10.8 (3.5-20.2), 
12.1 (5.6-26.4), and 12.7 (4.8-25.4); E, by ∆height SDS 1-6y tertiles, 10.8 (5.0-20.2), 12.4 (3.9-23.7), 
and 11.9 (4.5-24.8); F, by ∆weight-for-height SDS 1-6y tertiles, 7.6 (2.9-18.3), 15.9 (6.8-33.5), and 
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36 weeks). Two girls and 1 boy had been born large for gestational age (birth length or 
weight > 2 SD score), whereas none of the children had been born small for gestational age. 
When compared with girls, boys had higher mean length and weight at birth and at age 
1 year, and lower median serum IGF-1 concentration at age 6 year. When these anthro-
pometric measures were analyzed as standardized SD scores, only the difference in birth 
length between the 2 sexes remained significant.
A. Associations With Serum DHEAS Concentrations
There was a strong positive correlation between serum DHEAS concentration at ages 1 and 
6 years (r = 0.591, P < .01), and children in the highest DHEAS tertile at age 1 year had the 
highest DHEAS concentrations at age 6 years (Fig. 1A).
Table 1. Clinical and biochemical characteristics of the 78 children in the study
 All, n = 78 Girls, n = 43 Boys, n = 35 Pa
At birth     
 Gestational age, wks 40.4 (36.6; 42.1) 40.3 (36.6; 42.0) 40.7 (36.9; 42.1) .075
 Length, cm 50.3 (1.8) 49.6 (1.5) 51.1 (1.7) < .001
 Length SD score 0.0 (0.9) –0.3 (0.8) 0.3 (0.9) .003
 Weight, g 3650 (450) 3520 (450) 3800 (410) .006
 Weight SD score 0.1 (1.0) 0.0 (1.0) 0.2 (0.9) .249
 Weight-for-length, % 104.2 (7.7) 104.0 (6.9) 104.4 (8.6) .819
 Weight-for-length SD score 0.4 (0.9) 0.4 (0.8) 0.5 (1.0) .888
At age 1 y     
 Age, y 1.0 (0.9; 1.1) 1.0 (0.9; 1.1) 1.0 (0.9; 1.1) .365
 Length, cm 75.7 (2.5) 75.0 (1.9) 76.6 (1.9) .009
 Length SD score –0.4 (1.1) -0.4 (0.9) –0.3 (1.2) .931
 ∆Length SD score 0 to 1 y –0.3 (1.0) -0.1 (1.0) –0.6 (1.1) .024
 Weight, kg 9.8 (1.1) 9.4 (0.9) 10.3 (1.1) < .001
 Weight-for-length, % 100.1 (7.8) 98.8 (8.0) 101.5 (7.3) .132
 Weight-for-length SD score –0.1 (1.0) –0.2 (1.0) 0.1 (0.9) .152
 ∆Weight-for-length SD score 0 to 1 y –0.5 (1.1) –0.6 (1.1) –0.3 (1.2) .268
 DHEAS, µg/dL 2.1 (0.4; 27.6) 2.2 (0.4; 22.7) 1.8 (0.4; 27.6) .691
 IGF-1, ng/mL 71.0 (32.3; 184.8) 77.4 (32.3; 136.4) 64.2 (35.7; 184.8) .250
At age 6 y     
 Age, y 6.1 (5.3; 6.3) 6.2 (5.7; 6.3) 6.1 (5.3; 6.3) .630
 Height, cm 117.3 (4.4) 116.7 (4.4) 118.0 (4.3) .207
 Height SD score –0.3 (1.0) –0.3 (1.0) –0.3 (1.0) .833
 ∆Height SD score 1 to 6 y 0.1 (0.7) 0.0 (0.8) 0.1 (0.7) .883
 Weight, kg 22.0 (16.7; 44.0) 21.0 (16.7; 30.5) 22.0 (18.2; 44.0) .070
 Weight-for-height, % 99.6 (84.5; 174.3) 98.8 (84.5; 127.4) 99.8 (88.7; 174.3) .111
 Weight-for-height SD score 0.1 (1.0) -0.1 (1.0) 0.3 (1.1) .088
 ∆Weight-for-height SD score 1 to 6 y 0.1 (1.1) 0.1 (1.1) 0.2 (1.0) .717
 Waist circumference, cm 54.3 (47.0; 82.5) 53.5 (47.0; 68.5) 55.5 (50.0; 82.5) .034
 Waist-to-height ratio 0.47 (0.40; 0.65) 0.46 (0.40; 0.56) 0.47 (0.42; 0.65) .140
 DHEAS, µg/dL 12.1 (0.6; 76.1) 12.6 (0.7; 61.5) 9.1 (0.6; 76.1) .224
 IGF-1, ng/mL 183.2 (55.8; 355.6) 194.6 (55.8; 355.6) 159.8 (73.6; 264.8) .001
 Biochemical adrenarcheb, n (%) 8 (10.3) 4 (9.3) 4 (11.4) .758
 Clinical adrenarchec, n (%) 6 (7.7) 5 (11.6) 1 (2.9) .148
Continuous parameters with normal distribution are expressed as mean (SD), and those with nonnormal distribu-
tion as median (range). Bold values denote significant P values at the P less than .05 level. Conversion multipliers 
to SI units: DHEAS, µmol/l = µg/dL × 0.0271; IGF-1, nmol/l = ng/mL × 0.131.
Abbreviations: DHEAS, dehydroepiandrosterone sulfate; IGF-1, insulin-like growth factor 1.
aDifferences between sexes, analyzed using either the independent samples t test (normally distributed contin-
uous variables), the Mann-Whitney U test (nonnormally distributed continuous variables), or χ 2 test (categorical 
variables).
bDefined as serum DHEAS concentration ≥ 40 µg/dL.
cAdult-type body odor in 3 girls, greasy hair in 2 girls and 1 boy. Acne, comedones, or pubic/axillary hair were not 
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Serum DHEAS concentration at age 6 years correlated negatively with birth length SD 
score (r = –0.291, P < .01) and positively with first year ∆length SD score (r = 0.271, P < .05), 
and children in the lowest birth length tertile (Fig. 2A) and highest ∆length by age 1 year 
tertile (Fig. 2C) had the highest DHEAS concentrations at age 6 years. Birth size or growth 
measures by age 1 year did not associate with serum DHEAS concentrations at age 1 year. 
Neither birth weight, growth in weight-for-length by age 1 year, nor growth measures be-
tween the ages of 1 and 6 years had any significant associations with DHEAS concentrations 
at age 6 years (Fig. 2B, 2D, 2E, and 2F).
We found that serum DHEAS concentrations at age 6 years correlated positively with 
serum IGF-1 concentrations at age 1 (r = 0.289, P < .05) and 6 years (r = 0.291, P < .01), 
and that children in the highest IGF-1 tertile at age 1 year tended to have higher DHEAS 
concentrations at age 6 years (Fig. 1B).
B. Determinants for Higher DHEAS Levels at Age 6 Years
In age- and sex-adjusted logistic regression analyses, lower birth length, higher serum 
DHEAS concentration at age 1  year, and the change in length by age 1  year were 
determinants of falling into the highest DHEAS tertile at age 6 years (Table 2). In a mu-
tually adjusted stepwise regression model including age, sex, birth size, growth measures, 
and biochemical covariates at age 1 year, only higher DHEAS concentration at age 1 year 
was an independent predictor of falling into the highest DHEAS tertile at age 6 years 
(Table 2).
C. Associations with Serum IGF-1 Concentrations
Children in the highest IGF-1 tertile at age 1 year had the highest IGF-1 concentrations 
at age 6 years (median [interquartile range; IQR]; 145.3 ng/mL [124.1-187.2], 187.7 [160.1-
222.5], 205.6 [148.4-238.6]; P  =  .005). Growth in weight-for-height (141.9  ng/mL [119.4-
197.3], 187.3 [160.2-203.8], 197.9 [146.8-238.1]; P = .026) but not in height (P = .263) from 
ages 1 to 6 years associated with serum IGF-1 concentrations at age 6 years. Advanced early 
growth in length by age 1 year associated with higher IGF-1 concentrations at age 1 year 
(62.3 ng/mL [49.4-84.1], 69.1 [53.3-81.3], 86.5 [61.4-93.1]; P = .023), but we did not find sig-
nificant associations between birth size or growth in weight-for-length by age 1 year with 
IGF-1 concentrations at age 1 year.
Table 2. Probability of falling into the highest dehydroepiandrosterone sulfate tertile at age 6 years 
by birth size, growth measures, and biochemical covariates at age 1 year
 
Age- and Sex-
Adjusted Analyses Mutually Adjusted Modela
OR (95% CI) P OR (95% CI) P R2 (Model) P (Model)
Birth length SD score 0.43 (0.23 to 0.80) .008   0.422 .001
Birth weight SD score 0.64 (0.38 to 1.10) .105     
∆Length SD score 0 to 1 y 1.83 (1.09 to 3.08) .022     
∆Weight-for-length SD score 0 to 1 y 1.01 (0.63 to 1.63) .956     
∆Height SD score 1–6 y 1.06 (0.50 to 2.22) .887     
∆Weight-for-height SD score 1 to 6 y 1.02 (0.64 to 1.64) .927     
DHEAS SD score at age 1 y 2.71 (1.51 to 4.85) .001 5.42 (1.54 to 19.1) .009   
IGF-1 SD score at age 1 y 1.54 (0.94 to 2.53) .088     
Logistic regression models. Dichotomic dependent variable: highest serum DHEAS tertile at age 6 years (yes or 
no). Bold values denote significant P values at the P less than .05 level. 
Abbreviations: CI, confidence interval; DHEAS, dehydroepiandrosterone sulfate; IGF-1, insulin-like growth factor 
1; OR, odds ratio.
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4.  Discussion
In this longitudinal study, we evaluated the trajectories of DHEAS and IGF-1 from ages 1 to 
6 years and the associations of birth size and early growth with serum DHEAS concentrations 
at age 6 years in mostly term and appropriate for 78 gestational age–born Finnish chil-
dren. We observed that children in the highest DHEAS concentrations at age 1 year had 
the highest DHEAS concentrations at age 6 years. Furthermore, lower birth length and 
increment in linear growth during infancy (0-1 years) were associated with higher serum 
DHEAS concentrations at age 6 years. Despite the fact that birth or infant growth measures 
did not have significant associations with DHEAS concentrations at age 1 year, increased 
first-year growth in length indicated higher IGF-1 concentrations already at age 1  year 
and, in turn, IGF-1 concentrations at age 1 year correlated with DHEAS concentrations at 
ages 1 and 6 years. Based on these results, we suggest that early factors, including prenatal 
stress and higher energy supply in early childhood, induce increased early linear growth 
and later weight gain, leading to IGF-1–modulated early maturation of adrenocortical zona 
reticularis and higher serum DHEAS concentrations by mid-childhood.
The most important and novel finding in our study was that higher serum DHEAS 
concentrations could be detected already at age 1 year in those children with the highest 
DHEAS levels later in mid-childhood. To the best of our knowledge, this has not been re-
ported in previous studies. It has been reported that zona reticularis of the adrenal cortex 
becomes morphologically discernible at age 3 years [24] and that adrenal androgen secre-
tion (measured by sensitive gas chromatography–mass spectrometry urine androgen me-
tabolite analyses) increases gradually from around the same age [25]. However, children 
participating in the study by Remer et al [25] were older than 3 years and, based on our 
knowledge, measures of adrenal androgen secretion have not been reported in younger chil-
dren. One may also think that higher serum DHEAS concentrations at age 1 year could 
reflect late regression of the fetal zone of the adrenal cortex. We cannot exclude this possi-
bility in our study but, based on our knowledge, the fetal zone undergoes a rapid postnatal 
regression already in the first postnatal months [26].
The associations between birth size and early growth with later adrenal androgen se-
cretion in childhood have been reported in several studies. In a large British birth cohort 
study of 770 children, lower birth weight and rapid postnatal weight gain by age 3 years 
were associated with higher adrenal androgen levels at age 8 years [4]. In another large co-
hort study of 972 Chilean children, increased weight gain from ages 2 to 4 years and later 
increment in height gain from ages 4 to 7 years were associated with higher serum DHEAS 
concentrations at age 7 years [6]. On the other hand, children with early maturation of the 
adrenal zona reticularis leading to premature adrenarche have had growth advancement 
and increased weight gain already in the first years of their lives [11, 12, 27]. Our results 
are well in line with these findings from previous reports, except we failed to find a signif-
icant association between birth weight or infant weight gain and childhood serum DHEAS 
or IGF-1 concentrations. However, there was a tendency toward an association of lower 
birth weight and higher weight gain by age 1 year with higher DHEAS levels at age 6 years. 
It is possible that the association of early growth advancement and earlier maturation of 
the adrenal zona reticularis is related to nutrition. In addition to the studies showing the 
association between early weight gain and DHEAS levels [4, 6], there are other reports 
suggesting the effect of increased energy supply and nutritional status on childhood adrenal 
androgen secretion. Childhood body mass index correlated with higher childhood adrenal 
androgen secretion [28], and early adiposity rebound was associated with obesity [29] and 
premature adrenarche [12]. Also, fat mass and animal protein intake in childhood were pos-
itively associated with adrenal androgen secretion in one German study of 137 prepubertal 
children ages 3 to 12 years [8].
IGF-1 may be a key modulator in a process in which early growth advancement is as-
sociated with an earlier increase in adrenal androgen secretion. The inverse relationship 
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growth rate and current body size [10, 30, 32, 33] have been reported in several studies. In 
one of these studies, 50 children born small for gestational age had early catch-up growth 
and increased IGF-1 levels by age 3  years [30]. Similarly, lower birth weight, postnatal 
catch-up growth, and rate of weight gain by age 2 years were associated with higher IGF-1 
levels by age 5 years in a British cohort of 497 children [10]. On the other hand, children 
with premature adrenarche tend to have higher circulating IGF-1 levels than their nor-
mally developing peers [11, 13, 34, 35]. Our findings are well in line with these previous 
studies because increased growth in length by age 1 year and later increased weight gain 
by age 6 years were associated with higher IGF-1 levels at age 1 and 6 years, respectively. 
In addition to regulating human growth [36], IGF-1 may promote adrenal maturation and 
adrenal androgen secretion [37-39], and thus could be a link between postnatal growth rate 
and later childhood adrenal androgen secretion.
A major strength of our study is its prospective design. Limitations include the rela-
tively small sample size; some associations, especially those between low birth weight or 
rapid early weight gain and later serum DHEAS concentrations, might have been signif-
icant in a larger cohort. The lack of associations between serum DHEAS concentrations 
and body weight changes could also be explained by metabolic and nutritional status af-
fecting metabolic clearance rates of DHEAS and its binding proteins [40]. Regarding the 
prevalence of clinical and biochemical adrenarche in girls and boys, our findings in this 
cohort showed a similar pattern to that reported in another Finnish cohort [41]. Because 
the clinical presentation of adrenarche is sexually dimorphic [41], it might have been 
appropriate to analyze the sexes separately, which was not possible because of the small 
sample size. Because we did not have appropriate parental data, we were also unable to 
control the analyses with maternal or paternal developmental patterns. It should also be 
noted that only DHEAS but no other androgen precursors or active androgens were meas-
ured in this study.
In conclusion, higher circulating DHEAS and IGF-1 concentrations already at age 
1 year indicate higher DHEAS concentration at age 6 years. Moreover, lower birth length 
and early advancement in linear growth are associated with higher serum DHEAS 
concentrations at age 6 years. Similarly, early growth in length by age 1 year indicates 
higher IGF-1 levels at age 1 year, and increased weight gain from ages 1 to 6 years is 
associated with higher IGF-1 levels at age 6  years. Our findings suggest that part of 
adrenarchal programming already takes place by the end of infancy and that IGF-1 may 
be one of the modulators in this process. However, this preliminary hypothesis of an 
early programming of adrenarche needs to be confirmed in a larger cohort using a highly 
sensitive steroid panel.
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